Imaging in Adnexal Mass Evaluation: Review Article
Abstract
Background: Adnexal lesions are frequently encountered in radiological practice and encompass a broad spectrum of benign, borderline, and malignant conditions. Accurate imaging characterization is essential to prevent unnecessary surgery for benign lesions while ensuring timely referral of patients with suspected malignancy to gynecologic oncology services. Ultrasonography (US) remains the first-line imaging modality because of its accessibility, absence of ionizing radiation, and ability to assess lesion morphology and vascularity. Standardized systems such as O-RADS US and predictive tools such as the IOTA ADNEX model improve risk stratification; however, diagnostic performance may vary according to operator experience, patient population, and the presence of atypical benign features that overlap with malignancy. Magnetic resonance imaging (MRI) provides valuable problem-solving information for indeterminate, large, or complex adnexal lesions by characterizing tissue composition, enhancement, and diffusion features. It can reduce false-positive US findings, improve diagnostic specificity, support histologic subtype prediction, and guide appropriate surgical planning. This narrative review summarizes the current roles, strengths, and limitations of US, the ADNEX model, and MRI in evaluating adnexal lesions, with emphasis on imaging-based risk assessment and their complementary contribution to individualized patient management.